Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin futures surge to $41B as options hint at $80K max pain price target

Market News
05 Aug 2026
Bitcoin
View Source
Bullish
pluang ai news

Bitcoin futures contracts have quietly amassed over $41 billion, led by Binance and CME, signaling renewed institutional interest. The options market shows a max pain price target above $69,000, with Binance's max pain nearing $80,000, suggesting bullish sentiment despite Bitcoin trading around $64,700. Futures premiums have rebounded to 4.3%, indicating improving confidence, though recent option volumes show cautious new capital inflows. Upcoming CME expiries will be key to confirming whether bullish bets hold or lead to further liquidations.

More News

LivaNova price target raised after strong Q2 revenue and EPS beat, signaling growth in medical tech.

LivaNova price target raised after strong Q2 revenue and EPS beat, signaling growth in medical tech.

LivaNova's stock price target was raised to $85 following a strong Q2 performance with record revenue of $390.6 million, up 9.8%, and adjusted EPS of $1.26, beating estimates by 16.67%. The growth was driven by its Cardiopulmonary and Epilepsy segmen...

Company Fundamentals
Bullish
19 minutes ago
Glencore reports strong Q2 earnings, boosts shareholder returns with $1.5B cash and buyback

Glencore reports strong Q2 earnings, boosts shareholder returns with $1.5B cash and buyback

Glencore PLC reported better-than-expected Q2 results with earnings per share of $0.37 and revenue of $174.43 billion, driven by strong performance in its marketing and industrial divisions. Adjusted EBITDA surged to $10.11 billion, reflecting robust...

Company Fundamentals
Bullish
39 minutes ago
Cloudflare earnings preview: strong AI-driven growth but high valuation raises concerns

Cloudflare earnings preview: strong AI-driven growth but high valuation raises concerns

Cloudflare is set to report quarterly earnings with analysts expecting $0.27 EPS and $664.67 million revenue, reflecting strong growth driven by AI and edge computing innovations. Despite robust 31.55% revenue growth and 73% gross margins, the compan...

Company Fundamentals
Neutral
43 minutes ago
Supernus Pharmaceuticals posts negative ROIC, underperforming its cost of capital and peers.

Supernus Pharmaceuticals posts negative ROIC, underperforming its cost of capital and peers.

Supernus Pharmaceuticals reports a negative Return on Invested Capital (ROIC) of -9.12%, which is well below its Weighted Average Cost of Capital (WACC) of 6.92%. This indicates the company is not generating enough returns to cover its capital costs,...

Market News
Bearish
43 minutes ago
Wingstop's ROIC of 25.05% far exceeds its WACC of 10.18%, showing strong capital efficiency.

Wingstop's ROIC of 25.05% far exceeds its WACC of 10.18%, showing strong capital efficiency.

Wingstop Inc. demonstrates strong capital efficiency with a Return on Invested Capital (ROIC) of 25.05%, significantly higher than its Weighted Average Cost of Capital (WACC) of 10.18%. This results in an ROIC to WACC ratio of 2.46, indicating excell...

Market News
Bullish
43 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App